Medicōs Consultants leads a long-term collaborative project between the National Institutes of Health's (NIH) National Library of Medicine (NLM) and the Food and Drug Administration (FDA). Multiple objectives of the project include support for the FDA's Structured Product Labeling (SPL) initiative to support high-quality product images for oral solid dosage form medications marketed in the United States. The large scale image collection directly supported by the NLM has collected over 60,000 images to foster the development of high-performance computer vision algorithms in the support of aiding mobile pill identification applications. Medicos Consultants has provided the project management, technical and imaging expertise to develop both the FDA and the NLM initiatives.
Positron emission tomography (PET) is the unrivaled image modality for visualizing and measuring a wide range of (patho)physiological processes in vivo, depending on the positron emitting tracer being used. Its use in assessing regional myocardial blood flow (MBF) was demonstrated shortly after its introduction, changing the whole concept of non-invasive imaging of coronary artery disease (CAD). In contrast to single photon emission computerized tomography (SPECT), PET is inherently quantitative, due to the possibility of exact attenuation correction. Medicos Consultants is collaborating with leading academic institutions to facilitate the development of improved software analysis techniques.